drugset / Trial / NCT03652467
The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma
RandomizedParallel-groupTriple-blindTreatment
Summary
To investigate the safety and efficacy of deferoxamine (DFO) combined with conventional transarterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma (HCC).
Timeline
- Start
- 2018-09-01
- Primary completion
- 2022-09-01
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deferoxamine | Other / unclassified | — | — |